Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja

Q: How long will it take to read this news story?

The story "Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja" has 377 words across 17 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja" was covered 7 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 162 news stories per day. It's most recent story was published 6 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21918079</li><li>URL: https://beamstart.com/news/acquisition-of-bsv-to-aid-17227922835131</li></ul>

Business Standard Logo Business Standard 7h ago

Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja - Business Standard

Quick Summary:

The acquisition of Bharat Serums and Vaccines would add a lot of value, aiding future growth of Mankind Pharma, according to Vice Chairman and Managing Director Rajeev Juneja.

"One thing should be very clear, this acquisition is not to really add some kind of revenue, but to add a lot of value, future growth, entry barrier, super specialty business in Mankind," Juneja said in an analyst call.

On July 25, Mankind had announced that it will fully acquire Bharat Serums and Vaccines (BSV) from Advent International for an enterprise value of around Rs 13,630 crore.